Limited coverage drugs – febuxostat

Generic name                          

febuxostat

Strength

80 mg

Form

tablet

Special Authority criteria

Approval period                            

For the reduction of serum uric acid levels in patients with gout who demonstrate immune-mediated hypersensitivity to allopurinol.

Indefinite

Practitioner exemptions

None

Special notes

  • Details regarding a patient’s immune-mediated hypersensitivity reaction to allopurinol is required.

Special Authority request form(s)